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J O U R N A L O F T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y , V O L . 6 6 , N O . 1 6 , S U P P L S , 2 0 1 5 C57of genes using Affymetrix Gene Chip Human Genome U133 plus 2.0
chip (including 38,500 genes and 4,700 gene transcripts).
RESULTS Microarray results showed that after 48 hours, 4343 gene
transcripts differed (p<0.05) between controp group and HCY group.
Fuctional analysis showed a signiﬁcant number of genes to be
associated with apoptosis, cell cycle pathway, enzyme, immunity
protein, microtubular dynamic, nucleic acid binding,signal trans-
ducer. 3409 gene transcripts were up-regulated while 121 gene
transcripts were down-regulated in HUVEC treated with TXL. These
gene transcripts have been proved to relate to biological process,
molecular function and cellular structure. Signiﬁcant changes were
observed in genes involved in apoptosis, cellular proliferation, cell
signal transduction and oxidative stress. including vescular endo-
thelial growth factor (VEGF), IGF receptors, p42/44 mitogen acti-
vated protein (MAP) kinase, endothelial nitric oxide synthase (eNOS),
chemokine (C-C motif) ligand 2 (CCL2), chemokine (C-C motif) ligand
5 (CCL5), chemokine (C-X-C motif) ligand 10 (CXCL10), and toll like
receptor 3 (TLR3).
CONCLUSIONS TXL may protect endothelial function via the regula-
tion of gene expression which involved in apoptosis, cellular prolif-
eration, cell signal transduction and oxidative stress.GW26-e4023
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OBJECTIVES Cardiovascular diseases, such as hypertension, could be
programmed in fetal life. Prenatal lipopolysaccharide (LPS) exposure
in utero results in increased blood pressure in offspring, but the
vascular mechanisms involved are unclear.
METHODS Pregnant Sprague–Dawley (SD) rats were intraperitoneally
injected with LPS (0.79 mg/kg) or saline (0.5 ml) on gestation day 8,
10, and 12, and the vascular function was tested after treatment with
vehicle or TEMPOL in offspring at 15 weeks.
RESULTS The offspring of LPS-treated dams had higher blood pres-
sure and decreased acetylcholine (ACh)-induced relaxation and
increased phenylephrine (PE)-induced contraction in endothelium-
intact mesenteric arteries. Endothelium removal signiﬁcantly
enhanced the PE-induced contraction in offspring of control but not
LPS-treated dams. The arteries pretreated with L-NAME to inhibit
nitric oxide synthase (eNOS) in the endothelium or ODQ to inhibit
cGMP production in the vascular smooth muscle, had attenuated ACh-
induced relaxation but augmented PE-induced contraction to a larger
extent in arteries from offspring of control than those from LPS-
treated dams. In addition, the endothelium-independent relaxation
caused by sodium nitroprusside (SNP) was also decreased in arteries
from offspring of LPS-treated dams. The functional results were
accompanied by a reduction in the expressions of eNOS and soluble
guanylate cyclase (sGC) and production of NO and cGMP in arteries
from offspring of LPS-treated dams. Furthermore, LPS-treated dam’s
offspring arteries had increased oxidative stress and decreased anti-
oxidant capacity. Three-week treatment with TEMPOL, a reactive
oxygen species (ROS) scavenger, normalized the alterations in the
levels of ROS, eNOS, and sGC, as well as in the production of NO and
cGMP and vascular function in the arteries of the offspring of LPS-
treated dams.
CONCLUSIONS Prenatal LPS exposure programs vascular dysfunction
of mesenteric arteries through increased oxidative stress and
impaired NO-cGMP signaling pathway.GW26-e4401
MiR-195-3p/-5p decrease cardiac ﬁbroblast proliferation and the
transdifferentiation into myoﬁbroblasts
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OBJECTIVES MicroRNAs (miRNAs, miRs) contribute to many essen-
tial physiological and pathological processes including ﬁbrosis. This
study aims at investigating the role of miR-195-3p/-5p in cardiac
ﬁbroblast proliferation and the transdifferentiation into
myoﬁbroblasts.
METHODS Neonatal cardiac ﬁbrobasts (NRCFs) were isolated and
miR-195-3p/-5p was forced expressed with agomiRs. Proliferation asdetermined by EdU and Ki67 staining. a-SMA (a marker of myoﬁ-
broblast transdifferentiation) was determined by quantitative
reverse transcription polymerase chain reactions (RT-PCRs) and
western blotting (WB). Target genes of miR-195-3p/-5p were detected
by WB.
RESULTS In isolated primary neonatal cardiac ﬁbrobasts (NRCFs),
forced expression of miR-195-3p/-5p with agomiRs could attenuate
ﬁbrobast proliferation as determined by EdU and Ki67 staining
while inhibition of miR-195-3p/-5p with antagomiRs could increase
ﬁbrobast proliferation. By quantitative reverse transcription poly-
merase chain reactions (RT-PCRs) and western blotting (WB), a-SMA
(a marker of myoﬁbroblast transdifferentiation) was found to be
suppressed in the miR-195-3p/-5p agomiR-treated NRCFs at both
mRNA and protein levels, while was increased in the miR-195-
3p/-5p antagomiR-treated NRCFs. Moreover, Chek-1 was identiﬁed
as a target gene of miR-195-3p/-5presponsible for cardiac ﬁbroblast
proliferation and the transdifferentiation into myoﬁbroblasts by
RT-PCR and WB and immunoﬂuorescent staining. Silencing of
Chek-1 attenuates cardiac ﬁbroblast proliferation and the trans-
differentiation into myoﬁbroblasts as detected by a-SMA/EDU
staining. In addition, Chek-1 mediated the effects of miR-195-3p/-5p
in cardiac ﬁbroblast proliferation and the transdifferentiation into
myoﬁbroblasts.
CONCLUSIONS MiR-195-3p/-5p decrease cardiac ﬁbroblast prolifera-
tion and the transdifferentiation into myoﬁbroblasts. Therefore,
miR-195-3p/-5p might be promising therapeutic targets for cardiac
ﬁbrosis.
GW26-e4425
Effect of Extract of Leaves of Ginkgo biloba pretreatment on rat
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OBJECTIVES To study the effect and mechanism of Extract Leaves of
Ginkgo biloba (EGb) pretreatment on rat Cardiomyocytes with hyp-
oxia/reoxygenation (H/R) injury.
METHODS Cardiomyocytes were pre-incubated with extact leaves of
Ginkgo biloba, hypoxia reoxygenation model on myocardial ischemia
reperfusion injury after 2 h, and then detected the cell viability, MDA
content, SOD activity and GSH / GSSG ratio. The effects of EGb on
Keap1, Nrf2, GCLC and GSTP1 mRNA expression were determined by
RT-PCR method.
RESULTS The cell viability, SOD activity and GSH/GSSG ratio of EGb
pretreatment group increased signiﬁcantly compared with H/R group,
whereas the MDA content reduced signiﬁcantly; Keap1 mRNA
expression reduced signiﬁcantly, while Nrf2, GCLC and GSTP1 mRNA
expression increased signiﬁcantly, and the difference among with
three concentrations were conspicuous; these changes were reversed
after ATRA added.
CONCLUSIONS EGb plays a protection role in cardiomyocytes H/R
injury, and its mechanism was associated with Keap1 / Nrf2 / ARE
signaling pathway.GW26-e4505
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OBJECTIVES Type 2 ryanodine receptor (RYR2) hyperphos-
phorylation plays an important role in the development of myocardial
infarction caused heart failure (HF). However, it remains unclear
that whether there is similar process in the development of hyper-
tensive left ventricular hypertrophy (LVH) and heart failure (HF).
We tested the hypothesis that RYR2 hyperphosphorylation
also plays an important role in the development of hypertensive LVH
and HF.
METHODS Hypertensive LVH (70% diameter stenosis, n¼16) and HF
(90% diameter stenosis, n¼12) rabbit models were prepared through
